| Title |
Addition of long‐acting beta2‐agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2010
|
| DOI | 10.1002/14651858.cd005533.pub2 |
| Pubmed ID | |
| Authors |
Francine M Ducharme, Muireann Ni Chroinin, Ilana Greenstone, Toby J Lasserson |
| Abstract |
In asthmatic patients inadequately controlled on inhaled corticosteroids and/or those with moderate persistent asthma, two main options are recommended: the combination of a long-acting inhaled ss2 agonist (LABA) with inhaled corticosteroids (ICS) or use of a higher dose of inhaled corticosteroids. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 314 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Colombia | 1 | <1% |
| Ireland | 1 | <1% |
| Korea, Republic of | 1 | <1% |
| United Kingdom | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 307 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 42 | 13% |
| Researcher | 39 | 12% |
| Student > Bachelor | 32 | 10% |
| Student > Ph. D. Student | 26 | 8% |
| Other | 25 | 8% |
| Other | 69 | 22% |
| Unknown | 81 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 119 | 38% |
| Nursing and Health Professions | 28 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 18 | 6% |
| Unspecified | 16 | 5% |
| Social Sciences | 9 | 3% |
| Other | 33 | 11% |
| Unknown | 91 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2017.
All research outputs
#3,721,109
of 25,885,333 outputs
Outputs from Cochrane database of systematic reviews
#6,320
of 13,155 outputs
Outputs of similar age
#14,319
of 104,870 outputs
Outputs of similar age from Cochrane database of systematic reviews
#28
of 79 outputs
Altmetric has tracked 25,885,333 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,155 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.3. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,870 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.